Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions
暂无分享,去创建一个
[1] D. Rockey,et al. Cell and molecular regulation of endothelin-1 production during hepatic wound healing. , 2003, Molecular biology of the cell.
[2] B. Hinz,et al. Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.
[3] D. Brigstock,et al. Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.
[4] R. Lafyatis,et al. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen. , 2004, Arthritis and rheumatism.
[5] C. Denton,et al. Scleroderma--clinical and pathological advances. , 2004, Best practice & research. Clinical rheumatology.
[6] Hannu Kautiainen,et al. Arthritis Research & Therapy , 2009 .
[7] FernandoRodríguez-Pascual,et al. Functional Cooperation Between Smad Proteins and Activator Protein-1 Regulates Transforming Growth Factor-β–Mediated Induction of Endothelin-1 Expression , 2003 .
[8] E. Greene,et al. TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. , 2002, American journal of physiology. Renal physiology.
[9] T. Slowinski,et al. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. , 1997, The Journal of clinical investigation.
[10] A. Branzi,et al. The endothelin system in pulmonary arterial hypertension. , 2004, Cardiovascular research.
[11] M. Inaoki,et al. Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor‐β in a mouse fibrosis model , 2005 .
[12] F. Hirche,et al. Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of alpha2beta1 integrin. , 2006, Journal of cell science.
[13] Oliver Distler,et al. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. , 2007, Arthritis and rheumatism.
[14] A. Ghahary,et al. Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors , 2005, Molecular and Cellular Biochemistry.
[15] M. Clozel,et al. Role of endothelin in fibrosis and anti‐fibrotic potential of bosentan , 2005, Annals of medicine.
[16] F. Hirche,et al. Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of α2β1 integrin , 2006, Journal of Cell Science.
[17] E. Schiffrin,et al. Myocardial Fibrosis in DOCA-Salt Hypertensive Rats: Effect of Endothelin ETA Receptor Antagonism , 2000, Circulation.
[18] Jesús Prieto,et al. Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis. , 2005, The Journal of investigative dermatology.
[19] Wei Hu,et al. Angiopoietin-related growth factor (AGF) supports adhesion, spreading, and migration of keratinocytes, fibroblasts, and endothelial cells through interaction with RGD-binding integrins. , 2006, Biochemical and biophysical research communications.
[20] M. Mayes. Endothelin and endothelin receptor antagonists in systemic rheumatic disease. , 2003, Arthritis and rheumatism.
[21] J. Lasky,et al. Interstitial fibrosis and growth factors. , 2000, Environmental health perspectives.
[22] T. Yamamoto,et al. Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts , 2000, Archives of Dermatological Research.
[23] S. Werner,et al. Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.
[24] M. Inaoki,et al. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. , 2005, Journal of cellular physiology.
[25] S. Werner,et al. Paracrine regulation of keratinocyte proliferation and differentiation. , 2001, Trends in cell biology.
[26] D. Abraham,et al. Mechanisms and consequences of fibrosis in systemic sclerosis , 2006, Nature Clinical Practice Rheumatology.
[27] T. Yoshikawa,et al. SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[28] S. Jimenez,et al. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. , 1996, Genome research.
[29] H. Neumayer,et al. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. , 2000, American Journal of Respiratory Cell and Molecular Biology.
[30] D. Abraham,et al. Hammerhead ribozyme-mediated silencing of the mutant fibrillin-1 of tight skin mouse: insight into the functional role of mutant fibrillin-1. , 2006, Experimental cell research.
[31] B. Hinz,et al. Dissecting the roles of endothelin,TGF-β and GM-CSF on myofibroblast differentiation by keratinocytes , 2004, Thrombosis and Haemostasis.
[32] J. Horowitz,et al. Effects of the Protein Kinase Inhibitor, Imatinib Mesylate, on Epithelial/Mesenchymal Phenotypes: Implications for Treatment of Fibrotic Diseases , 2007, Journal of Pharmacology and Experimental Therapeutics.
[33] R. Lafyatis,et al. Fibulin-2 and fibulin-5 alterations in tsk mice associated with disorganized hypodermal elastic fibers and skin tethering. , 2004, The Journal of investigative dermatology.
[34] MartaRuiz-Ortega,et al. Endothelin-1, via ETA Receptor and Independently of Transforming Growth Factor-β, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells , 2005 .
[35] R. D. du Bois,et al. Constitutive ALK5-Independent c-Jun N-Terminal Kinase Activation Contributes to Endothelin-1 Overexpression in Pulmonary Fibrosis: Evidence of an Autocrine Endothelin Loop Operating through the Endothelin A and B Receptors , 2006, Molecular and Cellular Biology.
[36] T. Krieg,et al. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. , 2004, The American journal of pathology.
[37] M. Redondo-Horcajo,et al. Transforming growth factor-beta receptor requirements for the induction of the endothelin-1 gene. , 2006 .